Table 3.
HIV at Baseline, 4 Months, and 8 Months by Study Arm
| Intervention |
Waitlist control |
|||||
|---|---|---|---|---|---|---|
| Baseline |
4 Months |
8 Months |
Baseline |
4 Months |
8 Months |
|
| N = 25 | N = 23 | N = 17 | N = 25 | N = 20 | N = 17 | |
| Viral load, N (%) | ||||||
| Detectable | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (8.0) | 1 (5.0) | 3 (17.6) |
| Undetectable | 23 (92.0) | 22 (95.7) | 16 (94.1) | 22 (88.0) | 18 (90.0) | 14 (82.4) |
| Do not know or decline to answer | 2 (8.0) | 1 (4.3) | 1 (5.9) | 1 (4.0) | 1 (5.0) | 0 (0.0) |
| On ART, N (%) | ||||||
| Yes | 25 (100.0) | 23 (100.0) | 17 (100.0) | 25 (100.0) | 19 (95.0) | 17 (100.0) |
| No | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (5.0) | 0 (0.0) |
| Missed doses in the past 30 days,aN (%) | ||||||
| None | 10 (40.0) | 7 (30.4) | 8 (47.1) | 9 (36.0) | 5 (26.3) | 5 (29.4) |
| Any | 15 (60.0) | 16 (69.6) | 9 (52.9) | 16 (64.0) | 14 (73.7) | 12 (70.6) |
| Take ART correctly in past 30 days,aN (%) | ||||||
| Always | 13 (52.0) | 13 (56.5) | 13 (76.5) | 11 (44.0) | 7 (36.8) | 7 (41.2) |
| Not always | 12 (48.0) | 10 (43.5) | 4 (23.5) | 14 (56.0) | 12 (63.2) | 10 (58.8) |
| Rate ART ability,aN (%) | ||||||
| Very good–excellent | 19 (76.0) | 20 (87.0) | 16 (94.1) | 19 (76.0) | 17 (89.4) | 14 (82.4) |
| Good–very poor | 6 (24.0) | 3 (13.0) | 1 (5.9) | 6 (24.0) | 2 (10.6) | 3 (17.6) |
| Self-report medication adherence, mean (SD) | 87.4 (15.2) | 90.9 (9.9) | 91.8 (10.1) | 90.3 (7.8) | 87.7 (10.5) | 87.4 (11.2) |
| HIV treatment knowledge, N (%) | ||||||
| Adequate | 17 (68.0) | 19 (82.6) | 12 (70.6) | 14 (56.0) | 11 (55.0) | 13 (76.5) |
| Inadequate | 8 (32.0) | 4 (17.4) | 5 (29.4) | 11 (44.0) | 9 (45.0) | 4 (23.5) |
a
Total reflects that these questions were only asked of those who answered “Yes” to “Are you on ART?”
ART, antiretroviral therapy; SD, standard deviation.